CONTACT
+91 80 2808 2808
info@biocon.com
Biocon  /  Products  /  Biosimilars

BIOSIMILARS

Oncology

Sl. No Molecule Name
1 Trastuzumab
2 Bevacizumab
2 Pegfilgrastim

Diabetes

Sl. No Molecule Name
1 Insulin Glargine
2 Insulin Aspart
2 rh-Insulin

Immunology

Sl. No Molecule Name
1 Adalimumab
2 Ustekinumab
2 Etanercept

Ophthalmology

Sl. No Molecule Name
1 Aflibercept

Bone Health

Sl. No Molecule Name
1 Denosumab

OUR PATIENT STORIES

Insulin Glargine: Making Effective Diabetes Management accessible to all!

More  

India’s first US FDA approved Biosimilar Trastuzumab brings new hope to patients

More  

Bevacizumab shows the way for affordable, accessible cancer care!

More  

Know more
about us

>> Our Purpose
>> Biocon Biologics
>> Quality & Compliance

OUR KEY PRIORITIES
Siddharth Mittal
BOARD OF DIRECTORS
PRESS RELEASES
MEET OUR EMPLOYEES
Biocon Finance
FINANCIAL CALENDAR

Report adverse event/ side effects and/or product complaints for Biocon products.


Click here to report adverse event/side effects/product complaints and/or submit medical queries for Biocon Biologics Limited & BBL Affiliate products.

Click here to report adverse event/side effects/product complaints and/or post medical queries for Biocon Limited, Biocon Pharma Limited, Biocon Pharma Inc., Biocon Pharma UK Limited, Biocon Pharma Malta Ltd and Biocon FZ LLC products.





* Safe Harbour | Privacy Policy | Terms of Use © 2026, Biocon. All Rights Reserved
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>
Leaving the Biocon site!

You are now leaving the Biocon website for a Biocon affiliate site or third party site that is solely responsible for its content, including its compliance with guidelines applicable in certain geographies. Links to Biocon affiliate sites and third party sites are provided as a resource to our visitors and may not be governed by the same regulatory requirements applicable to this site and unaffiliated third party sites are subject to their own terms and data protection notices and practices. Moreover, if their third party site is subject to other country laws, regulatory requirements, data protection requirements or medical practices may differ between countries and the information provided therein may not be suitable for use in your country.

Agree >>